Session » Patient Outcomes, Preferences, and Attitudes Poster II: Patient Perspectives

Date: Tuesday, October 23, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2349

“I Was Prepared for the Other Side Effects; I Wasn’t Prepared for This One.”: A Qualitative Study of the Patients’ Experience of Inflammatory Arthritis Due to Immune Checkpoint Inhibitor Therapy for Cancer

9:00AM-11:00AM: Abstract Number: 2341

A Link between Quality of Patient–Rheumatologist Communication and Patient Healthcare Needs in Psoriatic Arthritis: An Online Survey of US-Based Patients and Rheumatologists

9:00AM-11:00AM: Abstract Number: 2342

A Pan-Canadian Study of Factors Associated with Perceived Doctor-Patient Communication in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2367

Acceptance Rate and Sociological Factors Involved in the Switch from Originator to Biosimilar Etanercept (SB4)

9:00AM-11:00AM: Abstract Number: 2355

Assessment of Barriers to Exercise Participation in Patients with RA

9:00AM-11:00AM: Abstract Number: 2353

Attitudes and Beliefs Regarding Methotrexate in Patients with Rheumatoid Arthritis: Results from Australian Rheumatology Association Database

9:00AM-11:00AM: Abstract Number: 2351

Attitudes Toward Telehealth Video Conferencing Among Patients with Rheumatic Disease

9:00AM-11:00AM: Abstract Number: 2347

Effectiveness of Shared Decision Making in Systemic Lupus Erythematosus Patients at OSU

9:00AM-11:00AM: Abstract Number: 2346

Emerging Ethical Issues in Physical Activity Monitoring of Persons Living with Arthritis: A Qualitative Evidence Synthesis

9:00AM-11:00AM: Abstract Number: 2350

Examining Ethnic Differences in Osteoarthritis (OA) Patients’ Knowledge and Attitudes Regarding Prescription Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

9:00AM-11:00AM: Abstract Number: 2363

Examining Workplace Supports in the Context of RA Disease Activity

9:00AM-11:00AM: Abstract Number: 2343

Exploring Decision Making Needs about Pain Management Among Adolescents with Juvenile Idiopathic Arthritis and Their Families: Preliminary Results from Interviews

9:00AM-11:00AM: Abstract Number: 2366

Facilitating Shared Decision Making in Psoriatic Arthritis: Factors Influencing Patient Preference for Treatment Mode of Administration

9:00AM-11:00AM: Abstract Number: 2373

How Do Patients Describe Their “New Normal” in Systemic Lupus Erythematosus? Use of Probabilistic Topic Modelling to Characterize Patients’ Experiences Recorded in an Online Health Community

9:00AM-11:00AM: Abstract Number: 2361

Needs, Experiences and Views of People with Rheumatic and Musculoskeletal Diseases about Self-Management Mobile Health Apps: Results of a Mixed Methods Approach

9:00AM-11:00AM: Abstract Number: 2368

Patient Preferences for Disease Modifying Anti-Rheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review

9:00AM-11:00AM: Abstract Number: 2369

Patients Preference Goes to MTX Autoinjectors over Prefilled Syringes: Results from a Phase III Trial

9:00AM-11:00AM: Abstract Number: 2360

Perceptions of Patients with Rheumatoid Arthritis about Self-Assessment of Disease Activity after Watching an Educational Video: Qualitative Pilot Results from the Auto-DAS in Middle Eastern Arab Countries Study

9:00AM-11:00AM: Abstract Number: 2356

Perceptions, Incentives, and Barriers to Clinical Trial Participation: Qualitative Evaluation of Lupus Patients, Enriched for Minority Participants

9:00AM-11:00AM: Abstract Number: 2354

Perspectives of Patients with Inflammatory Arthritis Regarding Cardiovascular Risk: A Qualitative Study

9:00AM-11:00AM: Abstract Number: 2370

Physician and Patient Preferences for Treating SLE: Insights into the Choice of Intravenous Infusion and Subcutaneous Injection

9:00AM-11:00AM: Abstract Number: 2352

Predictors of Patient and Physician Perceptions of Gout Disease Activity

9:00AM-11:00AM: Abstract Number: 2348

Prescriber Attitudes and Beliefs about Triple Therapy for Patients with Rheumatoid Arthritis: Knowledge Exchange in Internet Forums and Social Media

9:00AM-11:00AM: Abstract Number: 2357

Reactions to Online Testimonials: A Cluster Analysis of Risk Perception and Decision Making

9:00AM-11:00AM: Abstract Number: 2358

Risk Factors for Persistent Discordance in Global Assessment of Rheumatoid Arthritis (RA) Disease Activity between RA Patients and Their Physicians: Analysis Based on a Nationwide RA Database (2011 to 2016)

9:00AM-11:00AM: Abstract Number: 2365

Sex, Language and Age of Disease Onset Impact Illness Perceptions Among RA Patients

9:00AM-11:00AM: Abstract Number: 2372

Social Media Use for Health-Related Purposes By People with Rheumatic and Musculoskeletal Diseases – Results of a Global Survey

9:00AM-11:00AM: Abstract Number: 2345

Systematic Review of Patient Decision Aids for Chronic Musculoskeletal Pain

9:00AM-11:00AM: Abstract Number: 2359

Systemic Lupus Erythematous Outcome Concerns: Identifying Pain As the Major Discrepancy between Rheumatologists and Patients

9:00AM-11:00AM: Abstract Number: 2340

The Impact of Chronic Glucocorticoid Use Amongst Patients with Rheumatoid Arthritis: A Qualitative Study

9:00AM-11:00AM: Abstract Number: 2339

The Patient’s Perspective of Glucocorticoid Use: A Systematic Literature Review of Quantitative and Qualitative Studies

9:00AM-11:00AM: Abstract Number: 2344

Treatment Modes in Rheumatoid Arthritis: Moving Toward Shared Decision-Making

9:00AM-11:00AM: Abstract Number: 2362

Understanding Patients’ Perceptions of Gout

9:00AM-11:00AM: Abstract Number: 2371

Use of Social Media Among Patients with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 2364

Vasculitis Patient Journey: A Scoping Review of Patient Experiences with Vasculitis

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].